Below is a list of currently active Consult a Colleague volunteers. In the interest of full disclosure, ASH has asked each of the participating consultants in the Consult a Colleague program to identify any relationships that could influence - or could be perceived as influencing - the content of his or her responses. These disclosures are listed below.
Anemias
John Adamson, MD
Disclosures pending.
Nancy Berliner, MD
Disclosures pending.
David H. Henry, MD
Disclosures pending.
Stanley Schrier, MD
Disclosures pending.
Neal S. Young, MD
Disclosures pending.
Neil A. Zakai, MD, MSc
Disclosures pending.
Hematopoietic Cell Transplantation
Linda Burns, MD
Disclosures pending.
Joanne Kurtzberg, MD
Disclosures pending.
Robert Soiffer, MD
Disclosures pending.
Daniel Weisdorf, MD
Disclosures pending.
David Vesole, MD, PhD
Disclosures pending.
Hemostasis/Thrombosis
Kenneth Bauer, MD
Dr. Bauer indicated he had nothing to disclose.
Joel S. Bennett, MD
Dr. Bennett indicated he had nothing to disclose.
Alice Cohen, MD
Disclosures pending.
James N. George, MD
Consultant and Research Funding - Amgen, Inc.
Robert R. Handin, MD
Dr. Handin indicated he had nothing to disclose.
John Heit, MD
Disclosures pending.
Janna Journeycake, MD
Dr. Journeycake indicated she had nothing to disclose.
Nigel S. Key, MD, MBChB, FRCP
Disclosures pending.
Barbara A. Konkle, MD
Consultancy - Baxter Corporation, Bayer Corporation, Novo Nordisk
Membership Advisory Committee - CSL Behring
Michael H. Kroll, MD
Speakers Bureau - Eisai, Inc.
Ellis Neufeld, MD, PhD
Research Funding - Bayer, Ferrokin, Inc., Grifols, Novartis, Novo Nordisk
Membership Advisory Board - Grifols
Thomas L. Ortel, MD, PhD
Dr. Ortel indicated he had nothing to disclose.
Margaret Ragni, MD, MPH
Dr. Ragni indicated she had nothing to disclose.
Lymphoproliferative Disorders
Ranjana Advani, MD
Disclosures pending.
James O. Armitage, MD
Dr. Armitage indicated he had nothing to disclose.
George Canellos, MD
Disclosures pending.
Morton Coleman, MD
Disclosures pending.
Aronold S. Freedman, MD
Dr. Freedman indicated he had nothing to disclose.
Stephanie Gregory, MD
Research Funding/Grants - Astellas, Celgene, Cephalon, Genentech, GlaxoSmithKline, Immunomedics, NCIC CTG, Novartis, Onyx
Consultant - Amgen, Genentech (Roche), Novartis, Spectrum Pharmaceuticals
Speakers Bureau - Genentech (Roche), GlaxoSmithKline
Eric Jacobsen, MD
Disclosures pending.
Ann LaCasce, MD, MSc
Disclosures pending.
Brian Link, MD
Disclosures pending.
Kenneth McClain, MD, PhD
Stock Ownership - Johnson & Johnson Company
Expert Testimony - Cases regarding hemophagocytic lymphohistiocytosis
Board of Directors - Histiocytosis Association of America
Craig Moskowitz, MD
Disclosures pending.
Susan O'Brien, MD
Research Support/P.I. - Genentech, Berlex, Biogen Idec, Eli Lilly, Novartis, Bristol-Myers Squibb, GeminX, Genta, Hana Biosciences
Consultant - Genta, Sanofi-Aventis, Celgene
Scientific Advisory Board - GeminX, Biogen Idec, Eli Lilly
Carol Portlock, MD
Disclosures pending.
Kanti R. Rai, MD
Honoraria - Cephalon, Genentech
Membership Advisory Committee - Cephalon, Genentech, GlaxoSmithKline
Steven Schuster, MD
Disclosures pending.
Mitchell Smith, MD, PhD
Disclosures pending.
Sonali Smith, MD
Disclosures pending.
David Straus, MD
Disclosures pending.
John Sweetenham, MD
Dr. Sweetenham indicated he had nothing to disclose.
Jane Winter, MD
Disclosures pending.
Acute Leukemias
Anjali Advani, MD
Disclosures pending.
William Blum, MD
Disclosures pending.
Steven Coutre, MD
Disclosures pending.
Michael Deininger, MD, PhD
Disclosures pending.
Richard Furman, MD
Disclosures pending.
Jason Gotlib, MD
Disclosures pending.
Jonathan Kolitz, MD
Disclosures pending.
Richard Larson, MD
Research Funding - Ambit Bioscience, Amgen, Bristol-Myers Squibb, Celgene, Chroma Therapeutics, Novartis, Sanofi-Aventis
Consultancy - Antisoma, Caremark, Hana Bioscience, Novartis, Trubion
Royalties - UpToDate, Inc.
Honoraria - Bristol-Myers Squibb, Novartis
Equity Ownership - GlaxoSmithKline, Merck
Selina Luger, MD, CM, FRCP(C)
Dr. Luger indicated she had nothing to disclose.
Michael Mauro, MD
Disclosures pending.
Stephen Nimer, MD
Disclosures pending.
Olatoyosi Odenike, MD
Disclosures pending.
Gary Schiller, MD
Disclosures pending.
Stephen Sallan, MD
Research Funding - Enzon, Inc.
Expert Testimony - Legal case, Las Vegas, NV
Scientific Advisory Board - University of Chicago Cancer Center SAB
Wendy Stock, MD
Consultancy - Advisory boards for Berlex, Novartis, Genzyme, Eisai, Sunesis
Have received honoraria for attending advisory board meetings
Research Funding - Berlex through CALGB for correlative science studies
Martin Tallman, MD
Disclosures pending.
Geoffrey Uy, MD
Disclosures pending.
Meir Wetzler, MD
Disclosures pending.
Multiple Myeloma and Waldenström Macroglobulinemia
Morie Gertz, MD
Disclosures pending.
Sagar Lonial, MD
Consultant - BMS, Celgene, Millenium, Novartis
Research Funding - BMS, Celgene, Millenium, Novartis
Paul Richardson, MD
Speakers Bureau and Advisory Boards - Millennium, Celgene, Johnson & Johnson
Steven Treon, MD, PhD
Disclosures pending.
Myeloproliferative Disorders
Peter D. Emanuel, MD
Research Funding - Allos Therapeutics, Celgene
Ross Levine, MD
Consultancy - TargeGen
Ruben Mesa, MD
Dr. Mesa indicated he had nothing to disclose.
Josef T. Prchal, MD
Dr. Prchal indicated he had nothing to disclose.
Ayalew Tefferi, MD
Dr. Tefferi indicated he had nothing to disclose.
Srdan Verstovsek, MD, PhD
Research Funding - AstraZeneca, Celgene, Cephalon, Eli Lilli Company, Exelixis, Incyte, Novartis, Roche, SBIO
Myelodysplastic Syndromes
Bruce Camitta, MD
Dr. Camitta indicated he had nothing to disclose.
H. Joachim Deeg, MD
Disclosures pending.
Elihu Estey, MD
Dr. Estey indicated he had nothing to disclose.
H. Jean Khoury, MD
Dr. Khoury indicated he had nothing to disclose.
Alan F. List, MD
Disclosures pending.
Gail Roboz, MD
Honoraria - Celgene, Cephalon, ChemGenex, Eisai, EpiCept, Genzyme, Novartis
Mikkael Sekeres, MD, MS
Dr. Sekeres indicated he had nothing to disclose.
David Steensma, MD
Consultancy - Amgen, Novartis
back to top
